NCT00298610View on ClinicalTrials.gov

Safety and Efficacy Study of IV Artesunate to Treat Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Malaria
Interventions
DRUG

Artesunate

Intravenous Artesunate (2.4 mg/kg) once a day for three days

DRUG

Malarone

(proguanil/atovaquone) follow-on therapy (4 tablets once daily for three days)

Trial Locations (1)

Unknown

New Nyanza Provincial Hospital, Kisumu

All Listed Sponsors
collaborator

Military Infectious Diseases Research Program (MIDRP)

NETWORK

lead

U.S. Army Medical Research and Development Command

FED

NCT00298610 - Safety and Efficacy Study of IV Artesunate to Treat Malaria | Biotech Hunter | Biotech Hunter